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1. Introduction 
Kininogen is a plasma glycoprotein exhibiting 
various types of heterogeneity. First, the well charac- 
terized molecular forms high relative molecular mass 
(HMW) and low relative molecular mass (LMW) kini- 
nogens with different Mr-values of 120 000 and 
~50 000-78 000, respectively [ 1-3]. Another type 
of heterogeneity refers to the content of active brady- 
kinin segment covalently bound to the HMW and LMW 
kininogens and specifically split off by kallikrein (EC 
3.4.21.8). The LMW form, present in plasma in a 
higher concentration (~85% of total), is a potential 
source of the pharmacologically highly active brady- 
kinin peptide, apossible mediator in inflammation 
[4,5 ]. The HMW kininogen functions as a cofactor in 
the contact activation of F XIIa and F XIa thus initi- 
ating the cascade reactions of intrinsic blood coagula- 
tion [6] independently of the kinin segment but 
depending on a histidine-rich peptide fragment cova- 
lently bound to the L-chain [2,3]. In the native HMW 
kininogen this histidine-fragment is connected with 
the H-chain through the bradykinin segment. We 
have shown that intrinsic in vitro activation of kalli- 
krein through glass contact produces 3 -4  HMW molec- 
ular forms which can be determined by radioimmuno- 
assay (unpublished). It is likely that all forms of kini- 
nogen can be determined immunochemically through 
the antigenic determinants in the H-chain [7,8]. 
In [9,10] we investigated the charge heterogeneity 
of immunologically pure LMW kininogen prepared by 
Abbreviations: LMW, low relative molecular mass kininogen; 
SDS-PAGE, sodium dodecyl sulphate-polyaerylamide gel 
electrophoresis; Con A, concanavalin A -Sepharose 4B; RCA,, 
Ricinus eommunis agglutinin of 120 000 M r according to the 
nomenclature in [13]; IgG, immuno~obulin G 
using antibody specific affinity chromatography with 
monospecific anti-kininogen serum. The possibility 
that isoelectric heterogeneity primarily depends on 
the carbohydrate structure of kininogens was suggested. 
It seems that structural variations in the carbohydrate 
chains, other than the presence or absence of sialic 
acid residues alone, must play an important part in 
determining microheterogeneity. Therelationship 
between the interactions of kininogens with lectins 
and isoelectric heterogeneity has not yet been de- 
scribed. This report deals with an investigation ofkini- 
nogen heterogeneity utilizing the concanavalin A and 
Ricinus lectins. 
2. Materials and methods 
2.1. Kininogen preparations 
A crude LMW kininogen was prepared by Sephadex 
G-200 gel filtration of 500 ml human blood bank 
plasma (anticoagulant citrate-dextrose-phosphate, 
CPD) obtained from the Finnish Red Cross Blood 
Transfusion Service (by courtesy of Dr G. MyUylh). 
The Kay 0.34 fraction pool was collected and submitted 
to chromatography on DEAE-cellulose, DEAE- 
Sephadex and gel filtration as in [9,10]. A highly puri- 
fied kininogen (LMW) was isolated from 1000 ml 
ammonium sulphate precipitated plasma according to 
[10]. 
A kininogen (H-chain) was isolated from Cohn's 
plasma fraction IV as in [7,11]. It contained about 
equal amounts of pI 4.2 and 4.4 components and 
lacked the main isoelectric omponent of native plas- 
ma kininogen. This kininogen has the characteristics 
of the H-chain by molecular size, amino acid composi- 
tion, end-group analyses and antigenicity. 
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Native plasma kininogen was a single donor human 
blood sample freshly prepared for focusing using 1 ml 
anticoagulant (citric acid, dextrose, trisodium citrate) 
to 9 ml blood. The plasma was separated by centrifuga- 
tion 20 rain at 1000 X g, 4°C (ACD plasma). 
2.2. Affinity chromatography on lectins 
Ricinus communis agglutinin (RCAa) was isolated 
from 100 g castor beans (Deutsche Rizinus-Oelfabrik 
Boley Co.) essentially according to [12,13] by 
Sepharose affinity chromatography and subsequent 
Sephadex G-100 gel filtration. The RCA, agglutinin 
(195 mg) was dialyzed 20 h against 0.1 M NaHCOa, 
0.5 M NaC1 (pH 8.5). It was mixed with 20 ml CNBr- 
activated Sepharose 4B (Pharmacia) as in [14]. CNBr 
(Eastman Kodak Co.) was 20 mg/ml in 25 ml. After 
coupling the gel was left standing for 30 min in 1 M 
ethanolamine (pH 8.0) and washed with 0.1 M NaHCO3, 
1 M NaCI (pH 8.5) and 0.05 M Na-phosphate, 0.2 M 
NaC1 (pH 6.8) to remove unbound agglutinin and 
equilibrated with the latter buffer. 
The binding capacity assays for RCA1-Sepharose 
were performed in 2.5 ml 0.05 M phosphate buffer, 
0.2 M NaC1 (pH 6.8) and 0.5 ml RCA1-Sepharose 
and started by addition of different amounts of lactose 
(0.36-18 mg). The tubes were shaken for 1 h at 4°C, 
centrifuged (8000 X g, 20 rain) and the amount of 
unbound lactose determined as in [ 15]. 
Kininogen samples were applied on the RCA~ 
columns, washed with 20 mM phosphate buffer (pH 
7.2) containing 0.15 M NaC1 at 20°C. The bound 
Ricinus-reactive material was eluted with 0.1 M 
D-galactose (Merck) in the same buffer. Fractions of 
1.7-2.0 ml were collected. 
Columns of Con A-Sepharose (Pharmacia) were 
equilibrated with 0.01 M Tris-HC1, 0.1 M NaCt, 1 mM 
CaC12, 1 mM MgC12, 1 mM MnCI2, 0.02% NaNa, pH 7.5 
at 20°C. After sample application the column was 
washed with 30 ml sugar-free buffer and the glyco- 
proteins were eluted using 25 ml 0.1 M s-methyl-D- 
mannoside (grade III, Sigma) in the same buffer. Frac- 
tion volume was 2 ml. The binding capacity of Con 
A-Sepharose was determined in tubes in total volume 
of 3.4 ml essentially as in [ 16] using o~-methyl-D- 
mannoside (25-500/2g) and 0.4 ml Con A Sepharose. 
2.3. Neuraminidase treatment 
Crude kininogen 1 mg (A2~) and 0.2 units ofneur- 
aminidase (Clostridium perfringens, Worthington, 
0.63 U/rag) were incubated at 37°C for 1 h in 0.5 ml 
0.1 M acetate buffer (pH 5.0). hnmunological ctivity 
was measured without terminating the reaction. 
2.4. Radiolabelling 
Iodination was performed using the chloramine T 
method according to [ 17] with 10;tg immunoreactive 
LMW and 1 mCi Na12SI (New England Nuclear, carrier 
free). Radiolabelled LMW was separated from free 
12si by gel filtration on Sephadex G-75. Radioactivity 
was measured ina Wallac GTL 300 500 gamma sample 
counter. The specific activity was ~5-10/.tCi/~g im- 
munoreactive kininogen. 
2.5. Analytical procedures 
Determination of kininogen and plasma proteins 
was by Ouchterlony double immunodiffusion analysis 
[ 18] and Maneini single radial immunodiffusion [ 19]. 
Radioimmunoassay was performed by incubating 
0.2 ml samples or pure kininogen standards, 0.1 ml 
radiolabelled LMW (5000-10 000 cpm) with 0.1 ml 
diluted antiserum calibrated to bind 50% of the maxi- 
mal radioactivity at 4°C for 18 h. Normal rabbit serum 
5/B was added as carrier. Antibody-bound 12SI-labelled 
LMW was precipitated by adding 0.25 ml 1 : 10 diluted 
sheep anti-rabbit-IgG and incubated for 2 h at 22°C 
with shaking. The precipitate was collected by cen- 
trifugation (5000 × g, 4°C) and counted for radioac- 
tivity. 
Isoelectric focusing was performed in a LKB 8101 
column (110 ml) with 1% Ampholine (LKB) pH 3.5-5 
and 0.1% Ampholine pH 5-8  in a linear sucrose gra- 
dient. Fractions (~1 ml) were collected in ice using 
LKB peristaltic pump Zero-Max at 30 ml/h. The pH 
was measured within 2 h at 4°C with a Radiometer 
PHM 62 standard pH meter. 
Sialic acid was determined by the thiobarbituric 
acid method [20] after hydrolysis with 0.1 N sulfuric 
acid for 1 h at 80°C. Neutral sugar analysis was per- 
formed by the phenol/sulfuric acid procedure [15] 
employing mannose as standard. Total hexosamine 
was determined by the Elson-Morgan procedure [21] 
using glucosamine as standard. 
Homogeneity est on Ultrogel AcA (LKB) was done 
in 0.15 M NH4HCOa. All columns were calibrated with 
Blue Dextran 2000 (Pharmacia). 
SDS-PAGE was performed using 8% or 12% poly- 
acrylamide slab gels according to Laemmli [22]. 
Protein was determined by absorbancy at 280 nm 
usingA18% 0 = 10. 
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Fig.1. (a) Aff inity chromatography of 17.5 rng crude kini- 
nogen on Con A-Sepharose (0.8 cm X 22 cm, f low rate 
12 rot/h). Elution (at arrow) of bound protein with 0.1 M 
e-methyl-D-mannoside, fractions pooled as indicated, pool ]I  
(dialyzed, lyophilized) was chtomatographed further (b) on 
Ricinus-lectin RCA 1 (0.7 cm × 16 cm, 12 ml/h) elution (at 
arrow) with 0.1 M galactose. Fraction pool I (dialyzed, lyoph- 
ilized) was treated with neuraminidase and chromatographed 
on (c) RCAlqeCtin (0.7 cm X 16 cm, 12 ml/h). Protein by 
absorbancy (o-o) and mg kininogen (BKG) in fractions mea- 
sured by single radial immunodiffusion (open area). 
3. Results 
The result obtained by affinity chromatography 
with Con A of crude kininogen is demonstrated in 
fig. 1 a. Kininogen separated in a non-reactive (25%) 
and a reactive fraction (75%). The crude kininogen 
contained 9% immunoreactive kininogen, a2HS-glyco- 
protein and al-acid glycoprotein as main impurities 
and traces of albumin, ceruloplasmin and Gc-globulin. 
The binding capacity (Ka) of Con A was 12 mM -1 
with a-methyl-D-mannoside. TheCon A-reactive frac- 
tion (pool II) was further submitted to chromatog- 
raphy on RCArlectin with the binding capacity of 
0.5/~mol lactose/rag lectin. As demonstrated in fig.lb 
the reactive fraction from Con A did not bind to RCA1. 
After neuraminidase treatment of the dialyzed and 
lyophilized protein fraction binding to RCA~ occurred 
as seen in fig. 1 c. 
The binding to Con A-Sepharose was repeated with 
purified, homogeneous (fig.2) LMW kininogen in com- 
parison to the H-chain. The results are shown in fig.3. 
The distribution between the reactive (pool 2) and 
non-reactive (pool 1) LMW kininogen was 78% and 
22% respectively, in agreement with the earlier esult 
(fig.3a). 
As demonstrated in fig.3b, 47% of the kininogen 
H-chain passed through and 53% was bound to Con A. 
The molecular size of the reactive and the non-reactive 
material was the same, 58 000, determined by SDS- 
PAGE (fig.3b inset). The inset in fig.3a shows SDS- 
PAGE analysis of purified LMW kininogen. 
The antigenicity of the reactive and non-reactive 
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Fig.2. Homogeneity est on Ultrogel AcA 54 (0.9 cm X 30 cm, 
8 ml]h, V o = 11 ml, 0.15 M NH4HCO 3) of I mg highly puri- 
fied LMW kininogen (recovery 98%). Protein profile (o-o),  
kininogen (BKG) ( . . . .  ) by single radial immunodiffusion. 
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fractions ofkininogen H-chain (fig.3b) was investigated 
by radioimmunoassay using anti-kininogen-H-chain 
serum. As demonstrated in fig.4 the Con A reactive 
fraction produced a radioimnmnoassay inhibition 
curve parallel to the standard curve. The slightly dif- 
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Fig.3. Aff'mity chromatography on Con A-Sepharose 
(0.8 cm × 22 cm, flow rate 10 ml]h) of (a) 1 rag homogenous 
highly purified LMW kininogen and (b) 4.8 mg H-chain prep° 
aration. Buffer, elution of lectin-bound fractions and symbols 
as in fig.la. Insets: SDS-PAGE analysis (a) in 12% gel of 
8 #g highly purified LMW and (b) in 8% gel of 6 tzg Con A non- 
reactive (left) and 5 #g Con A-reactive kininogen. M r markers 
78 000, 68 000, 43 000 and 11 700. 
BIB. 
1.0 
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1.5 1'0 1 0'0 
no BKG 
Fig.4. Radioimmunoassay inhibition curves obtained with the 
Con A-reactive (o - -o )  and non-reactive ([]--D) fractions 
of kininogen H-chain in comparison with a standard of LMW 
(o - -e )  kininogen. B/B o is the ratio of radioactivity bound 
in the presence and absence of inhibitor. 
ferent slope obtained with the non-reactive fraction 
still needs verification. 
The non-reactive LMW fraction (fig.3a, pool 1) was 
dialyzed against distilled water, lyophflized, dissolved 
in 50 gl distilled water and iodinated. This material 
(total 3.7 X 106 cpm) was submitted to isoelectric 
focusing. Fig.5a presents the percentage distribution 
of radioactivity in relation to pI: 19% at pI 4.2, 12% 
pI 4.3, 21% pI 4.4, 41% pI 4.5-4.6 and 7% pI 4.7. 
When the Con A reactive fraction (fig.3a, pool 2) 
was focused (fig.5c) the corresponding distribution 
was: 13% at pI 4.2, 28% pl 4.3, 28% pI 4.4 and 
31% pI 4.5-4.6. Fig.5b shows the focusing pat- 
tern of native plasma kininogen obtained with 2 ml 
fresh human ACD plasma. In all the cases the pI 4.5 
component constitutes the main isoelectric fraction 
which in native plasma was 47%. 
The carbohydrate compositions of LMW kininogen 
and H-chain are shown in table 1. The mol/mol content 
was calculated from the respective molecular masses 
obtained by SDS-PAGE (fig.3a,b insets). The total 
carbohydrate content of H-chain was somewhat lower 
(14.4% compared to 18.6%). 
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Fig.5. (a) Percent distribution of radioactivity after isoelectric 
focusing of 12 ~tg ~2SI-labelled Con A non-reactive LMW. (b) 
Percent distribution of kininogen after focusing of 2 ml nor- 
real human single donor plasma determined by single radial 
immunodiffusion. (c) Percent distribution of 330/zg Con A 
reactive LMW after focusing. The focusing was performed 
between pH 3.5-5.0 (" - "), 68-70 h, 4°C, 500-1000 V, frac- 
tion volume 1-1.2 ml; protein prof'de ( - - ) .  
4. Discussion 
The separation of kininogen into two components 
on Con A-Sepharose (riga a,3a) demonstrates a 
heterogeneity depending on carbohydrate structure. 
This adds a third type of heterogeneity common among 
Table 1 
Carbohydrate composition of purified kininogens 
% w/w mol/mol 
LMW H-chain LMW H-chain 
Neutral hexoses 
(as mannose) 6.0 4.8 19 16 
Hexosamine 
(as glucosamine) 7.6 5.3 25 18 
Sialic acid 
(as N-acetylneur- 
aminic acid) 
Total 
5.0 4.3 
18.6% 14.4% 
9.4 8.4 
plasma glycoproteins [23] to the earlier known heter- 
ogeneities depending on molecular size or charge [9,10]. 
The structural basis for the ability of Con A to bind 
kininogen has so far not been studied. The results show 
that the galactose residues are masked demonstrated 
by the binding to RCA1 lectin after removal of all 
sialic acid. The binding differences when comparing 
Con A and RCA1 suggest that glucosamine and man- 
nose residues are available for binding despite the 
masked galactose residues. This is in agreement with 
recent findings comparing Con A and RCA lectin 
binding with vitamin Bl~-binding protein and c~-feto- 
protein [24,25]. As seen in table 1 the only slightly 
higher sialic acid content in the LMW kininogen indi- 
cates that the sialic acid is primarily bound to the 
H-chain. This is in agreement with the low isoelectric 
point found with the isolated, pure H-chain [11] 
differing completely from the normal distribution of 
heterogeneous kininogen [8,10]. Present results ustain 
an earlier suggestion [ 11 ] based on fractionation of 
the H-chain by polyacrylamide g l filtration that varia- 
tions in the location of carbohydrate units determines 
this type of charge heterogeneity manifested by low 
isoelectric points. 
With LMW kininogen (fig.5) the isoelectric pattern 
did not appreciably differ comparing the Con A reac- 
tive and non-reactive fractions from the distribution 
ofpI  components in native plasma. The main fractions 
focused normally at pI 4.5-4.6 in agreement with 
earlier findings [10]. The role played by differences 
in carbohydrate and/or polypeptide portions of the 
kininogen molecule in the charge heterogeneity remains 
unclear. An earlier result [26] would suggest hat the 
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desialylated kininogen focuses uniformly at pI 5.4-5.5. 
The participation of carbohydrates in the antigenic 
determinants of glycoproteins was discussed in [28]. 
We have indicated [7] that the H-chain plays a domi- 
nant part in the antigenicity ofkininogen. Comparison 
of the carbohydrate content with that of the LMW 
kininogen (table 1) shows that the main part of sialic 
acid and other carbohydrates are bound to the H-chain. 
As shown in [ 11 ] the H-chain kininogen preparation 
produces no detectable L-chain after reduction on 
SDS-PAGE. The result in fig.4 suggests that mannose 
and N-acetylglucosamine do not influence the anti- 
genicity of the Con A reactive fraction. The slight 
difference in slope obtained with the non-reactive 
fraction would sustain the masking of these carbo- 
hydrates althougt{ both fractions had similar content 
of sialic acid. 
Con A chromatography was applied for the purifi- 
cation ofkininogen in [27]. We calculated their distri- 
bution to be 22% and 78% between the Con A non- 
reactive and reactive kininogen, respectively, which is 
in agreement with these findings. As seen by the SDS- 
PAGE patterns in fig.3b affinity chromatography on
Con A-Sepharose can apparently be used to remove 
the main impurities ceruloplasmin and c~2HS-glyco- 
protein from the H-chain preparation [ 11 ]. Most 
of these proteins bound to Con A under these experi- 
mental conditions. On the other hand neither with 
LMW nor the H-chain preparations the Con A non- 
reactive fraction was totally free from contaminating 
plasma proteins. 
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